[Principles of the treatment of peritoneal carcinomatosis due to colorectal cancer. Current review and update] (Q82296124)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420876%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

review article

1 reference

title

[Principles of the treatment of peritoneal carcinomatosis due to colorectal cancer. Current review and update] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420876%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

peritoneal carcinomatosis

1 reference

based on heuristic

inferred from title

author name string

Alberto Gómez-Portilla

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420876%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Iñaki Cendoya

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420876%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Iñaki López de Tejada

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420876%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Iñaki Olabarria

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420876%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Luis Magrach

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420876%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Concepción Martínez de Lecea

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420876%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Alberto Gil

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420876%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Mercedes Valdovinos

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420876%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Iñaki Larrabide

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420876%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Natalia Ruiz de Alegría

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420876%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

José Luis Fernández

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420876%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Irune Cachorro

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420876%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

María del Carmen Contreras

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420876%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Josu Castañeda

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420876%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Arantxa Uriarte

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420876%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

María Victoria Boado

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420876%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

José Antonio Urturi

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420876%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Miguel Angel Ulibarrena

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420876%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

1 January 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420876%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420876%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

77

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420876%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420876%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

6-17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420876%20AND%20SRC:MED&resulttype=core&format=json

Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Metastatic colorectal cancer: treatment challenges and quality of life.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Metastatic colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Adenocarcinoma of the sigmoid colon: sites of initial dissemination and clinical patterns of recurrence following surgery alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Intraperitoneal chemotherapy for colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Peritoneal seeding following potentially curative resection of colonic carcinoma: implications for adjuvant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Hemodynamic and cardiac function parameters during heated intraoperative intraperitoneal chemotherapy using the open "coliseum technique".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Nonoperative management of primary colorectal cancer in patients with stage IV disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis from nongynecological cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Multimodal treatment of peritoneal carcinomatosis and sarcomatosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Successful management of microscopic residual disease in large bowel cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

It's what the surgeon doesn't see that kills the patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Peritoneal carcinomatosis from colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Predictors of short-term survival and progression to chemotherapy in patients with advanced colorectal cancer treated with 5-fluorouracil-based regimens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Cost-effectiveness of second-line treatment with irinotecan or infusional 5-fluorouracil in metastatic colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Combined irinotecan, oxaliplatin and 5-fluorouracil in patients with advanced colorectal cancer. a feasibility pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Advanced colorectal cancer treatment in Europe: what have we achieved?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Raltitrexed (Tomudex) administration in patients with relapsed metastatic colorectal cancer after weekly irinotecan/5-Fluorouracil/Leucovorin chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

A historical perspective on colorectal liver metastases and peritoneal carcinomatosis: similar results, different treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Management of peritoneal-surface malignancy: the surgeon's role

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

7 January 2021

Peritonectomy procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

7 January 2021

Peritonectomy procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Treatment and prevention of peritoneal carcinomatosis from colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Use of nitrogen mustard in treatment of serous effusions of neoplastic origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

The rationale of perioperative intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Rationale for hyperthermia with intraoperative intraperitoneal chemotherapy agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Does hyperthermia induce peritoneal damage in continuous hyperthermic peritoneal perfusion?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Safety monitoring of the coliseum technique for heated intraoperative intraperitoneal chemotherapy with mitomycin C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Study of the pharmacokinetics of mitomycin C in humans during intraperitoneal chemohyperthermia with special mention of the concentration in local tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Heated intraoperative intraperitoneal mitomycin C and early postoperative intraperitoneal 5-fluorouracil: pharmacokinetic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Human pharmacokinetic study of heated intraperitoneal oxaliplatin in increasingly hypotonic solutions after complete resection of peritoneal carcinomatosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Pharmacokinetics of heated intraoperative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Quantitative prognostic indicators of peritoneal surface malignancy: carcinomatosis, sarcomatosis, and peritoneal mesothelioma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

[Treatment of peritoneal carcinomatosis using complete excision and intraperitoneal chemohyperthermia. A phase I-II study defining the best technical procedures]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Complications of heated intraperitioneal chemotherapy and strategies for prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Intraperitoneal hyperthermic treatment for peritoneal dissemination of colorectal cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Intraperitoneal hyperthermic perfusion with mitomycin C for colorectal cancer with peritoneal metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Peritoneal carcinomatosis treatment with curative intent: the Institut Gustave-Roussy experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Treatment of peritoneal carcinomatosis with intent to cure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

[Peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemohyperthermia]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from appendiceal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Peritoneal carcinomatosis from adenocarcinoma of the colon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-739X%2805%2970796-X

10.1016/S0009-739X(05)70796-X

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16420876%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference